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ABSTRACT  
Biobank research deals with personal information and data from blood and tissue analysis, making the 
questions of legitimate recruitment of participants and handling of their data to be intimately connected 
with the issue of privacy. Thus, identification of the privacy interests of biobank participants is vital to the 
legitimacy of biobank projects. In this article, we ask: How do participants articulate the nature of privacy 
issues in biobanking? Here we report from a focus group study on biobank participants’ view of privacy 
and consent in relation to biobank research. Based on our analysis, we found that participants viewed 
privacy as a concept that describes several dimensions of the fundamental need to be recognized and 
respected as an individual and as a person. Interestingly, the needs to be recognized and respected were 
also viewed as the basic purpose of biobank consent. 
 
 
INNLEDNING 
 
Protection of privacy is a prominent concern in the 
ethics of biobanking. According to Bialobrzeski et al., 
this is because biobanks are on contradictory missions: 
“on the one hand serving the collective welfare through 
easy access [of resources] for medical research, on the 
other hand adhering to restrictive privacy expectations 
of people in order to maintain their willingness to par-
ticipate in such research” [1, p. 9]. The sensitivity of the 
personal information collected from biobank partici-
pants in addition to the potential sensitive nature of re-
sults generated by the analysis of the biological samples 
calls for strict protection of data. To implement strin-
gent privacy protection regimes threatens to hamper, 
however, the researchers’ purpose of setting up a bio-
bank, as well as the participants’ in making their con-
tributions: To facilitate the availability of large datasets 
of genetic and health related information from groups 
of people for scientific inquiry. 
 Moreover, progress in genomics, bioinformatics, 
computation and data mining increases the potential to 
identify persons even in an anonymised set of genetical 
data [2-5]. This has prompted some [2,6] to advocate 
for a proper governance structure that regulates privacy 
risks in order to protect research subjects. In contrast, 
others [7] suggest that we should accept the potential 
ramifications of this situation and stop guaranteeing 
privacy protection for biobank participants. Thus bio-
bank participation will be restricted to persons willing 
to take the risk of partly or fully disclosure of their sub-
mitted and research generated biobank information. 
 The legitimacy of different approaches to partici-
pant privacy protection will depend on our understan-
ding of privacy and privacy interests. However, while 
the concept of consent is widely discussed in biobank 
ethics, the concept of privacy is black boxed: The 
importance of privacy protection and the right to pri-
vacy are highly emphasized, but are more often stated 
than discussed in biobank ethics. 
 This lack of discussion would be appropriate if the 
nature of privacy was obvious, or if a right to privacy 
is nothing but shorthand for more basic rights. Privacy 
protection in the context of biobanking could in the 
latter case be accomplished by protecting a more basic 
interest. Privacy protection could be no more than an 
aspect of respecting participants’ autonomy, for instan-
ce. If that were the case, then to protect the privacy 
interests of participants would be the same as to res-
pect their autonomy. 
 According to Lunshof et al.’s strategy privacy could, 
in fact, simply be viewed as an aspect of autonomy: 
Privacy protection concerns just the right of partici-
pants to control, or to forfeit the control of access to 
personal information. The literature on the nature of 
privacy, however, shows that neither the nature of pri-
vacy nor its relation to other concepts like autonomy is 
obvious [8-11]. Moreover, it is not easy to state clearly 
both what we want to protect in protecting participants’ 
privacy, as well as why we want to protect the privacy 
of biobank participants [12-15]. 
 In biobanking, privacy issues are introduced in the 
consent process where information about privacy risks 
and protection policies is given to the participant. The 
potential participant has thereby the opportunity to 
reflect on potential privacy risks and ultimately decide 
whether to participate or not [16]. By giving their 
consent the participants “waive prohibitions on actions 
that would otherwise be intrusive”, in the opinion of 
Manson and O’Neill [17, p. 97]. 
 In order to be able to discuss privacy issues, both in 
general and within biobank ethics, it is important to get 
a clearer view of what privacy means, why we think 
privacy should be protected, and how we regard pri-
vacy to be protected by the participants’ consent. In 
addition, to ground legitimate consent policies and 
sound governance of participant data, a better under-
standing of what privacy entails is needed. Although 
ethical challenges of biobank research have been given 
broad attention in expert forums, even the experts 
270  L.Ø. URSIN AND K.S. STEINSBEKK 
struggle to find good ways to meet specific ethical 
challenges related to privacy. 
 The purpose of this paper is to peek into the black 
box of privacy by drawing on biobank participants’ 
thoughts and insights on the issue of privacy and the 
related issue of consent. In this article we will present 
and discuss our findings from focus group interviews 
on the nature of privacy and consent. Knowledge of 
biobanks or biobank research is not widespread in the 
general public, as shown by a recent report on “Euro-
peans and biotechnology" [18]. To establish a point of 
departure and to ensure some familiarity of biobanks 
amongst the discussants the focus groups were formed 
by participants of the Norwegian HUNT1 study. Using 
HUNT biobank as a backdrop, we aimed in the focus 
group discussions to arrive at an understanding both of 
the general nature of privacy, as well as its special 
relevance to biobanking. In these group sessions we 
moved from discussions of privacy to discussion of 
consent, in order to clarify the interrelation between 
these issues. 
 Below we will present our approach and findings 
and then we briefly discuss privacy and consent in 
light of these findings. 
 
 
METHODS 
 
As part of the research project In genes we trust? Bio-
banks, commercialisation and everyday life, we sought 
to explore lay person’s attitudes towards questions 
concerning privacy, consent, commercialisation and 
genetic research in biobank contexts. Conducting focus 
group interviews is a well-established method in quali-
tative research such as in applied research and evalua-
tion [19,20]. This method enables us to investigate 
“common sense beliefs and public topoi” among lay 
persons [21-23] and it facilitates the exploration of how 
participants use their existing knowledge in discussing 
and making sense of potentially elusive, quite abstract 
and hypothetical concepts. 
 
Approval  
This study was approved by the Norwegian Data In-
spectorate via the Norwegian Social Science Data 
Services (NSD) who handles the statutory data privacy 
requirements in the research community in Norway. 
 
Recruitment of participants and pre-interview 
preparations  
In 2010 lay persons from the county of Nord-Trøndelag 
were invited to participate in focus group discussions. 
Nord-Trøndelag is the catchment area of the Norwegian 
HUNT-study [24,25]. This is among the largest (popu-
lation-based) health studies ever performed worldwide. 
[24]. This study has a thirty year long history, has been 
highly visible locally and has enjoyed uniquely high 
participation rates [24,26,27]. HUNT is publicly owned 
                                                           
1 HUNT is an acronym for Helseundersøkelsen i Nord-Trøndelag, 
which translates into The North Trøndelag health study.  
and run within an academic setting. Since 1984 HUNT 
has conducted three rounds of recruitment from the 
general population of the county of Nord- Trøndelag. 
Blood samples were collected in the last two rounds, 
conducted in 1995-97 and 2006-08. This collection of 
samples constitutes the HUNT biobank, and has been 
used for medical research (from 2002 onwards) inclu-
ding genetic analysis.  
 In recruiting participants from a population where 
people are familiar with HUNT, our aim was to enable 
the focus group discussants to actively use HUNT, in 
addition to their general life experiences, as a point of 
reference when examining the topics of privacy and 
consent.  
 We strategically recruited participants to eight focus 
groups via local contact persons identified by members 
of our research group. Selection of participants aimed 
to represent different age groups and different geogra-
phical areas. They were recruited based on either an 
association with a patient interest group, public health 
organisation or on where they worked. For a more 
detailed description of this process please see [28]. 
 To reduce feelings of stress and frustration when 
discussing unfamiliar topics, as we had experienced in 
a previous focus group study [29] as well as has been 
reported by Haddow et al. in a similar study [30], we 
offered participants a chance to prepare for the discus-
sion by providing them with an information packet prior 
to the group sessions. This packet included an infor-
mation leaflet about HUNT and a description of the 
topics and types of questions that would be discussed. 
 
The focus group session  
Standard focus group procedures as described by 
Krueger [30,31] were followed. A detailed interview 
guide with six major topics was developed in our re-
search group2 and used in each session. Only issues 
pertaining to privacy and consent are reported here. 
Each focus group interview was moderated by two 
facilitators and lasted up to 2 hours. The individual 
topics and the main questions of each topic were 
introduced using a Power Point presentation. The pre-
sentation slides had headings, images and questions 
aimed to facilitate the discussions by providing speci-
fic and well-known starting points. All questions were 
open, in order to allow participants to contribute to the 
discussion in their own way, and to let the issues they 
found relevant emerge. The basic format of the group 
discussion was structured to facilitate conversations 
among the invited participants. The main questions 
were nevertheless actively followed up by additional 
enquiries from the facilitators. 
 The Norwegian heading of one of the focus group 
slides reads “Personvern og privatlivets fred”. This lite-
rally translates into: “Protection of persons and private 
                                                           
2 The research group of the “In genes we trust? Biobanks, commer-
cialisation and everyday life”-project consists of Berge Solberg and 
John-Arne Skolbekken, both researchers working at NTNU, in 
addition to the authors of this article. 
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life”. The word personvern in the Norwegian original 
means “protection of information about a person”, 
while fred means both peace and to be left alone. Thus 
a more accurate rendering of the heading would be: 
“Protection of information about a person and his abi-
lity to peacefully pursue his private life unsolicited.” 
The three main questions posed were: “What do you 
consider to be sensitive information? Who decides what 
kind of information is sensitive? Why should one treat 
sensitive information with care?” Questions 2 and 3 
were introduced mainly in order to facilitate a good 
discussion of the first question. The word sensitive is 
used instead of private in order to avoid the private/ 
public distinction, aiming to ease the participants’ free 
assessment of what is private and why. 
 The issue of consent was introduced with a slide 
containing the heading “Informed consent” and a short 
paragraph informing the participants that blood and 
tissue samples taken for diagnostic purposes could be 
interesting to use in various research projects. Two 
questions were posed on the slide: “Does use of samples 
already taken for diagnostic purposes in research 
require informed consent?”; “How would you justify 
such a consent requirement?” On this topic, question 1 
was introduced in order to facilitate a discussion on the 
second question. 
 
Data collection and analysis  
Each participant provided written consent and the ses-
sions were digitally recorded, transcribed into full text 
and anonymized. The content of the responses from 
our discussants was analysed in an inductive manner 
by identifying emergent themes. The process is in-
formed by Massey, Krueger, Mayring and Malterud  
[20-32-34], with an emphasis on thematic analysis. 
Our aim was to identify what Massey [20] describes as 
”themes [that] may reflect a range of individual atti-
tudes, opinions, and beliefs, as well as touching on 
otherwise unarticulated norms and social values” [35, 
p. 22]. The analysis of the thematic content was refined 
in two-way discussions where the transcripts were 
revisited several times. The condensed results and their 
discussions are presented in the following sections. 
 
 
FINDINGS 
 
The focus group participants struggled to articulate 
what is private, and why. The discussions in all groups 
followed a pattern of repeated but ultimately failed 
attempts at arriving at a consensual and comprehensive 
identification of the nature of privacy. But even if it 
might have remained a mystery for the discussants what 
privacy is at the end of each session, the participants’ 
reflections informed a more nuanced description of 
privacy. And even if no consensus was reached, the 
discussants’ observations and opinions were quite 
succinct. They offered precise descriptions of several 
dimensions of privacy. These dimensions, we think, 
are not wholly reducible to each other. In this way, the 
focus group discussions suggest that privacy is a com-
plex concept that cannot be understood or defined by a 
simple set of criteria. 
 Moving from a discussion of the concept of privacy 
to a discussion of the rationale of consent requirements, 
the discussants remembered clearly that they had given 
their consent to participate in HUNT. But why? Seve-
ral reasons were offered, reasons that add up to a com-
plex justification of consent requirements, rather than 
being reducible to a single justifying principle. 
 
Privacy  
Based on our analysis, the best general description of 
privacy given in our groups was that privacy “concerns 
the integrity of the individual in society at large. You 
should be allowed to be yourself. (…) I think that is 
what is at stake here at the fundamental level – it con-
cerns the identity of persons.” What does it mean that 
privacy is a matter of integrity and identity? We found 
that the discussants emphasized the following dimen-
sions of privacy: Self-determination, harm, respect, 
freedom, confidentiality, and discretion. 
 Self-determination, often expressed as control, was 
the first dimension that participants identified, and it 
appeared to be the most important aspect of privacy in 
their minds. One of the participants simply defined 
sensitivity in terms of self-determination: “Private in-
formation is the information I want to control myself.” 
A corollary of this definition is that the kind of infor-
mation I do not want to control myself is not sensitive. 
This position was also expressed: “If you consider 
something as private, even if it is a good thing or does 
not matter at all, then it is not up to others to decide 
whether we can pass it on or not, if it is sensitive for 
you.” Thus there are no inherently private matters, 
anything can be private – or not. Privacy as something 
strictly relative to and defined by the individual was by 
several discussants taken to justify – or at least explain 
– that each person has a zone of privacy that is idio-
syncratic: “We all have different zones, I should say, 
some people keep others at a greater distance [than 
others].” 
 However, the definition of privacy in terms of self-
determination was indirectly questioned by other parti-
cipants: “A lot of people place information about them-
selves [on a webpage] without any thought of how 
sensitive it is”. Such a statement would not make any 
sense if every individual is the final arbiter of what is 
sensitive or not. For this statement to make sense, it 
must either be the case that some kinds of information 
are inherently sensitive, or that we can judge whether 
something is sensitive for someone else. Both of these 
conditions are touched on in the following excerpt 
from the transcription:  
M (moderator): The first topic is protection of persons and 
private life, and there we have put up some pictures and 
then the question is what do you consider to be sensitive 
information? 
7: Personal health information, what is the matter with us 
and these things…  
 (…) 
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3: That will depend a bit on… if it is someone else that has 
posted it and you suddenly realize that you are depicted 
on a public page without any consent then it is a totally 
different matter than if you have provided the information 
on your own Facebook-page. 
 (…) 
6: You mentioned Facebook or other websites where a lot of 
people place information about themselves without any 
concern of the sensitivity of it, at the time, but might 
regret it later on.  
The participants here discuss a more complex view of 
privacy, where self-determination is important, but not 
the sole criterion for what is deemed sensitive and 
therefore needs to be kept private. 
 Potential harm was also voiced as an important 
dimension of privacy. Of course, not any harm will do. 
That I have tripped and injured my knee playing soc-
cer would not by itself classify as a private matter. It 
must be a harm related to personal health information 
i.e. harm that is harmful for the integrity of the person. 
Here we are back to privacy as identity, meaning that 
private matters might be harmful to your moral charac-
ter or social role, to who you are – or are perceived to 
be. 
 The harm condition is highlighted by the remark on 
the sensitivity of the different kinds of information 
transfer involved in biobank participation: “I think that 
what I give away in a conversation [or a questionnaire] 
is much more sensitive than that blood. (…) Yes, be-
cause it relates to something about me.” Other partici-
pants thought that genetic information was very private. 
The private character of genetic material generally de-
pended on the chance of misuse of genetic information. 
 Thus anonymisation of personal data, the use of agg-
regate data at a group level or use of data in relation to 
non-stigmatizing diseases, made the genetic material 
lose or not acquire a private nature. However the col-
lection and collation of information that is not private 
on its own can make it sensitive: “Information can 
become sensitive if someone goes out and gathers a lot 
of information that is not sensitive, but that becomes 
sensitive if you put it together and make a profile on 
people, then all of a sudden it can turn into something 
nasty and sad.” The private nature of genetic material 
is thus not inherent, but dependent on the use to which 
it is put, how it is put together, and the risks involved. 
 Nevertheless, the participants thought that being in-
cluded in a biobank, that is the very act of giving away 
any information, was a matter of self-determination. 
This indicates the respect dimension of privacy. The 
ontological aspect – and immense importance of – 
guarding and keeping a private sphere is beautifully 
captured in the following dialogue on why potential 
biobank participants should be asked for their consent:  
4: It has something to do with your self-image (…) that I am 
self-determined. 
1: That I am the master of my domain. 
4: Yes, that I do not dissolve into nothingness, and that 
everyone can help themselves to what’s mine. (…) It has 
something to do with respect.  
If a person’s private sphere is not respected, the very 
social existence of that person is threatened. To be 
approached as person, not as a mere research object, is 
a matter of being respected. The dimension of respect 
is important to guard against an all-encompassing exi-
stential harm, and to be recognized as a fellow citizen 
taking part in a shared moral and political realm. 
 The freedom dimension of privacy is expressed in 
the interest in positively creating your own self-image: 
“In a way, you want to decide for yourself who you 
are, and not be defined by others from what they hear 
and know from other sources”. The participants recog-
nized a need to be free from social control, and also to 
be able to free yourself from the past: “I do not google 
myself all that often, but in fact I did yesterday and 
then (…) some old stories popped up that I think 
should have been passed over in silence today.” 
 The freedom dimension of privacy emphasizes an 
interest in being a dynamic and to some extent an elu-
sive person. This dimension has a clear strategic aspect, 
like the possibility to apply for a job in all confidentia-
lity, in order to avoid speculation and unsettling 
questions from you current colleagues and employer: 
“Doesn’t she like it here?” The freedom dimension of 
privacy highlights a person’s interest in being a self-
defined agent writing his or her own story: “… in a 
way you want to decide yourself who you are going to 
be, instead of from what others hear and know about 
you from other sources”. And at the most fundamental 
ethical level, the possibility to create a room where 
you are free to move and act without the others being 
able to completely predict, track, and explain your 
movements is a basic condition for being (regarded as) 
a moral agent at all. 
 The confidentiality dimension was expressed by the 
participants both in a narrow and a broad sense. The 
narrow sense is a matter of you telling someone some-
thing of a private nature about yourself that you expect 
them to keep to themselves or within the relevant 
group, or that someone finds out something about you 
that you expect them not to tell anyone else than you 
or members of the relevant group. “… I have an ex-
pectation that it [information or biological materials] 
should be treated in a certain way (…) as in a relation-
ship of confidentiality”. These relations of confidentia-
lity form the basis for how and why we involve our-
selves with others: “(…) in a family some information 
will be considered to be sensitive outside but not 
inside of the family. In health related questions, some 
information can be sensitive for everybody except my 
doctor (…)”. 
 In the broad sense, confidentiality is a matter of 
trusting others to treat you with respect and not ruin 
your private realm: “(…) it is about respect for the one 
you get information about (…)”. Others have a duty 
not to harm you, and to leave you some elbow room in 
social space. We depend on others in general to uphold 
our private realm, to trust the ones we enter specific 
relations of confidentiality with: “The interpersonal 
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relationships of trust are important here. If you violate 
such a relationship, then ok another person will lose 
trust in you. But he might also lose trust in other peo-
ple, and in that way you will do much greater harm.” 
Here the interpersonal nature of privacy is emphasized, 
not just in the way that my explicit wish to keep 
something private should be respected, but that there is 
an obligation on the confidant to assess what is private 
or not in different social settings. 
 The final dimension of privacy we identified in the 
focus group discussions is discretion. Discretion here 
concerns the duty of the individual to keep her own 
private matters out of the public sphere. The cultural 
and temporal aspect of the discretion dimension em-
phasizes that what is considered improper to talk about 
is relative to time and place:  
1: Yes, if you look back 30-40-50 years, cancer and all those 
things should not be talked about; it was all taboo those 
days. 
6: But there has been a change lately, taking place in the last 
4-5 years, making things very personified, I feel, meaning 
that each individual person has been given all the respon-
sibility for her own development (…)  
The discretion dimension has a political aspect that 
connects to the possibility of harm: “(…) to express 
your political point of view is not a problem in Nor-
way, but there are other places in the world where that 
is very problematic (…). ”The cultural and temporal 
aspect of discretion emphasizes both that the border is 
dynamic, and that privacy is more than just a residual 
category but is a cultural construction upheld by social 
ideals of personhood, tolerance and subcultures. The 
concepts of the private and the public are defined by 
each other. 
 
Consent  
Turning from privacy and sensitivity toward consent in 
biobank research, it is interesting to note the reappear-
ance of the dimensions they had discussed in relation 
to the issue of privacy. The discussion of consent re-
volved around how individuals relate to each other, to 
the biobank institution, and the state. The basic question 
seemed to be: How do we create the kind of society we 
want to be a part of? Here respect, trust, self-
determination and ownership were the predominant 
motivations given for consent requirements. 
 The respect dimension loomed large among our dis-
cussants as a basic justification for requiring informed 
consent. When asked by the moderator in one of our 
focus groups: “Given the current Norwegian system 
[publicly funded research with the approval of regional 
ethical committees], do you think it would be okay if 
the general rule was that there was no consent require-
ment for this type of use [research on de-identified 
samples]?”, the discussion continued like this:  
1: That would be fine by me; it would be okay that no 
consent was required. 
2: I think that, you would feel a bit, you would feel a bit 
better if you have given your consent, right? 
5: A bit more important.. 
2: Yes, a bit more important in the big picture, I think. It 
really does not matter for me as a person [to give my 
consent], but that feeling might be a part of it. 
M: But what is it a feeling of? 
2: That you are a bit more important in the system, that you 
take part and contribute in a better way. 
1: That you are respected. 
2: That you are taken seriously and not just tossed in.  
Even though a clear sentiment in many of our groups 
was that consent is not always necessary, they all had 
an unambiguous understating that consent relates to 
respect. As we can see from this excerpt of the discus-
sion, the kind of respect participants were concerned 
about had to do with recognition: To be viewed as a 
distinct person rather than just a faceless donor. The 
obligation to ask for participants’ consent in this per-
spective stems from a corresponding right to be treated 
as a person, rather than a corresponding right to self-
determination. To be asked for consent is important as 
a matter of courtesy, rather than as matter of individual 
autonomy:  
4: That kind of question, it is, I think it’s like, most people 
answer yes. But there will always be some people that.. 
?:  Weirdoes ((laughter)) 
4:  Yes, one expects that people answers yes to this [to take 
part in HUNT]. 
M: What do you think about duty here? Is it almost like a 
duty? 
3:  Yes. It’s a bit like a duty. 
2:  There is a factor there, yes.  
These discussants voiced a mild moral duty to take 
part that was present in all our groups, and the respect 
dimension should be understood in relation to this. The 
participants are happy to take part, and the researchers 
should show their gratitude in treating the participants 
in a decent way: “I think this has to do with good man-
ners, to ask for permission to use it [a tissue sample]”. 
 The respect dimension borders to the trust dimen-
sion of consent. In asking for participants’ consent, re-
searchers show that they are people who can be trusted 
to handle participants’ contributions in a decent way: 
“You might feel a bit more assured that it [a blood 
sample] in good hands, too, if they ask for your consent, 
that it’s not totally let loose.” The biobank institution 
and relevant governing bodies also becomes more 
trustworthy in openly asking for consent, rather than 
potentially leaving participants wonder what is going 
on with their samples. Some discussants expressed that 
consent enhanced trust in involving the participants in 
the ongoing biobank research in a proper way: “If you 
have to get consent from people you have to argue (…) 
I think it is very good that you have to argue why this 
research is important.” Even if the discussants did not 
question the ethical standard of HUNT research, they 
emphasized the importance of HUNT to be totally 
open about their research. 
 Although the discussants generally viewed HUNT 
participation as a mild moral duty, they did not think 
participation should be mandatory. Thus they did not 
argue for a legal duty to take part. In accordance with 
this they viewed consent as an indispensable tool for 
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participants’ self-determination: “Nobody knows when 
it’s okay for us [to have one’s samples included in 
research]. We might have differing views on when it’s 
okay or not.” Some discussants thought that it was 
important in principle to limit states’ ability to gather 
biobank data on citizens without participants’ permis-
sion: “ It has something to do with the respect for the 
individual (…) he/she is supposed to be both sacro-
sanct and autonomous, this is what this is all about”. 
 The discussants were quite divided on the question 
of ownership to their contributed genetic and health 
related information. Some expressed some form of ow-
nership relation to their blood samples, in line with the 
policy of HUNT in regarding the participants as the 
owners of the samples in the sense of being the ones 
who can ask for their withdrawal from the biobank at 
any time. Other discussants had no more relation of 
ownership to their samples, than to the hair cut off at 
the hairdressers. An important reason for their offhand 
rejection of ownership is the anonymity of the samples 
used in HUNT research projects: “As long as they 
don’t use names or, it’s just a number and then I don’t 
think it [to ask for consent] is important. It’s almost 
like donating your body [when you do not need it any 
more].” In this analogy, the samples cease to be a part 
of a living person when they are donated, and becomes 
like mere organs suitable to help other persons. 
 
 
DISCUSSION 
 
The focus group discussions brought forth a hetero-
geneous description of the nature of privacy. This 
correlates well with the arguments from Daniel Solove 
[36,37]. Inspired by Ludwig Wittgenstein [37], he des-
cribes privacy as a concept dealing with phenomena 
that has family likenesses rather than a common core: 
Privacy is like a family and has dimensions instead of 
characteristic family traits. And like family traits, the 
dimensions of privacy makes situations resemble one 
another in a way that makes it natural to keep them 
together. What makes family members resemble one 
another is however not one common trait, but rather 
overlapping likenesses, like some individuals sharing a 
long nose, while others share a small mouth. What 
makes situations of privacy concern resemble one 
another is likewise not one single criterion, but over-
lapping likenesses. 
 The overlapping dimensions of privacy expressed 
by our discussants are summed up in the six dimen-
sions of self-determination, harm, respect, freedom, 
confidentiality, and discretion. Initially, self-determi-
nation and harm was at the forefront of the discussions 
of privacy. What is private was partly seen as some-
thing I decide myself, and both actual breach of priva-
cy as well the worry of breach of privacy can harm me 
as a person. However, as the discussions progressed, 
and the participants described the different situations 
where privacy concerns are involved, they had to make 
use of one or more of the six dimensions mentioned 
above. The heterogenic nature of privacy in various 
contexts, as well as its varying importance for different 
people, largely explains why it was difficult for our 
participants to describe the privacy issues at stake in a 
short and concise manner. In addition, the participants 
expressed rather different levels of concern for their 
own privacy and to what degree of risks they could 
accept. 
 HUNT participants had accepted the risks and felt 
that their privacy was both respected and protected by 
the governing structure of HUNT. For them, the cru-
cial points were that they could control whether to 
participate or not, and that the potential for breach of 
privacy was kept to a minimum. Although they all felt 
that contributing personal information to biobank 
research had something to do with privacy all but two 
were still part of the biobank endeavour. This can be 
said to correlate with findings in a previous quantita-
tive study by Kaufman et al. [16] which shows that 
even though one has concerns for breach of privacy 
one still is willing to participate. Their study showed 
that 90% of the respondents were concerned about 
privacy in the biobank context yet 84% supported the 
general idea of large cohort studies and 60% said that 
they definitively or probably would participate. 
 In a couple of groups the policy chosen for the Perso-
nal genome project (PGP) [7] was discussed. The PGP 
policy entails full disclosure of research participants’ 
personal information and analytical results via the in-
ternet. As HUNT promises privacy and confidentiality 
in the consent process his strategy was alien to the dis-
cussants, and strongly questioned. Again, privacy pro-
tection was seen to be vital. Not necessarily vital in the 
sense of protection against harms, as they perceived 
the risk of harm as minimal in the current Norwegian 
society, but vital in the way of showing respect for 
their participation and of themselves as individuals. 
 As stated in the introduction, the participants en-
counter privacy issues through the consent process. 
Consent has been a cornerstone of ethical conduct in 
medical research during the last decades. But it still 
remains controversial what constitutes a valid consent, 
when consent is necessary and in which form it should 
be issued and used. This is also the case in biobank 
research [17,39-41]. Against the background of this 
controversy as well as the intimate link between priva-
cy and consent we wanted to get insights from actual 
biobank participants on their views of what consent 
represent to them. Our aim in this study was not to 
discuss the legitimacy of various types of consents in 
biobank research. Nevertheless, it is interesting to note 
that our discussants saw consent to accommodate a 
number of purposes. Spelling out these purposes is an 
aid in showing us why the issue of consent, like 
privacy, is a complex and challenging one for biobank 
research. 
 The participants highlighted the dimensions of res-
pect, trust, self-determination and ownership. The im-
portance of respect and recognition was voiced in all 
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our focus groups. This is also seen in a recent paper 
from Simon et al. [42] where the sentiment from their 
informants were that to “ask for consent” is needed in 
biobank research, this is “the right thing” to do, and 
necessary to honour respect. In addition to being 
shown respect by requesting participants’ consent, the 
participants are given recognition and granted access 
to information. Thereby, they are put in position to 
assert some kind of control, and are recognised as 
independent and reflecting individuals and not mere 
members of the masses. 
 For our discussants, to be recognised as a person 
provides a social obligation on the part of the resear-
cher to treat the participants in a decent way. If the 
image of the person is lost, it is easier to let go of one’s 
ethical standards. Of course, the participants paradoxi-
cally express just the opposite wish; to be nothing but 
a faceless donor in a de-identified biobank. But this air 
of paradox is dissolved once we remember the point of 
anonymity; to protect the interests of a person. 
 In the context of biobanking, the promise of anony-
mity was seen as essential but nevertheless taken for 
granted by many of the discussants. Interestingly 
neither our discussants nor we brought a scenario of 
breach of confidentiality in HUNT into the discussions. 
This most likely reflects previous findings by Anton-
sen [43] in an earlier qualitative focus group study 
where the discussants voiced strong trust that HUNT 
would not breach confidentiality. They deemed breach 
of confidentiality to be a threat to privacy and would 
therefore clearly be detrimental to their trust in HUNT 
[43]. However, privacy dimensions such as confidenti-
ality did not seem to be decisive for whether a person 
participates in HUNT or not. 
 On the one hand, discussants in our study expressed 
the interest of the individual in being able to abstain 
from or to withdraw from biobank participation. On 
the other hand, they expressed the participants’ interest 
in being able to be involved in, informed of, and bene-
fit from biobank participation. These dual interests of 
biobank participants are emphasized by Mats Hansson: 
“In order to deal with the challenges in the social 
complex world of human beings, great demands are 
placed on the capacity of individuals, both to protect 
their own perspective and also to protect their partici-
pation with others” [9, p. 152]. 
 Society and its citizens share this dual interest: The 
private sphere of the individual must be protected in 
order to enable him and her to be a moral person and 
be protected from “dissolving into nothingness”. At 
the same time society must be tolerant and safe in or-
der to make the individual able to take part instead of 
having to retreat into a private realm. 
 To protect the privacy of biobank participants by 
anonymity is a way to prevent harm to participants and 
protect their dignity. Anonymity protects participants’ 
dignity by keeping their biobank information out of 
sight for the public eye. Harm or loss of dignity redu-
ces the freedom of persons to lead their lives the way 
they want to. Anonymity gives the participants the 
freedom to realise their interest in contributing to bio-
bank research. At the same time, as suggested by the 
discretion dimension of privacy, increased tolerance in 
society towards currently stigmatizing information 
about individuals is another way of protecting their 
dignity. 
 Interestingly, our discussants touched upon the no-
tion that the requirement of consent forces the research 
institutions and the researchers themselves to think 
through the purposes and ramifications of their activi-
ties. To know that the process leading up to the making 
of the consent form has taken place in the biobank 
institution was expressed by an informant as by itself 
reassuring for the participants. The awareness of such 
a process can be seen as more vital to the trustworthi-
ness of the biobank than the act of signing the consent 
form for the individual. Several discussants viewed a 
transparent organisation and easy access to information 
for participants as sufficient for biobank recruitment 
purposes. Thus the crucial part of informed consent 
was information rather than consent. 
 In giving their consent, participants waive their 
right not to contribute data and samples to the biobank. 
They are given the opportunity not to consent. Interest-
ingly this aspect was only minutely touched upon in 
our discussions. The contrary sentiment seemed more 
important; that asking for consent actually makes the 
research endeavour more accountable by showing 
respect for the contributor. In this way the discussants 
spoke of redeeming a feeling of control, of being res-
pected and reassured – because they have been given 
the opportunity to consent. 
 
 
CONCLUDING REMARKS 
 
Our focus group discussants arrived at a complex view 
of the nature of both privacy and consent. They 
emphasized several dimensions of privacy; self-
determination, harm, respect, freedom, confidentiality, 
discretion, and of consent; respect, trust, self-
determination, ownership. The importance of privacy 
protection was strongly advocated, for a complex set 
of reasons. The paramount purpose of asking for con-
sent was to show respect, and in order to respect bio-
bank participants’ privacy its non-reducible dimensions 
should be taken into account. In the era of globalisa-
tion, data mining and data sharing, in general and in 
medical research in particular, increased threats to pri-
vacy are envisioned. To be able to still conduct good 
medical research, to be able to recruit participants in 
for example to biobank research it is important to be 
aware of, discuss, assess and reduce such threats. This 
requires an understanding of the complex nature of 
privacy and the role of consent in medical research in 
general and in biobank research in particular. 
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